Search Results

There are 19156 results for: content related to: Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?

  1. Opioid system blockade decreases collagenase activity and improves liver injury in a rat model of cholestasis

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 3, March 2007, Pages: 406–413, Samira Kiani, Mohammad R Ebrahimkhani, Ahmad Shariftabrizi, Behzad Doratotaj, Seyedmehdi Payabvash, Kiarash Riazi, Mehdi Dehghani, Hooman Honar, Alaleh Karoon, Massoud Amanlou, Seyed M Tavangar and Ahmad R Dehpour

    Version of Record online : 2 MAR 2006, DOI: 10.1111/j.1440-1746.2006.04260.x

  2. Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress

    Liver International

    Volume 27, Issue 4, May 2007, Pages: 538–547, Seyedmehdi Payabvash, Saman Kiumehr, Behtash Ghazi Nezami, Ali Zandieh, Pasha Anvari, Seyed Mohammad Tavangar and Ahmad Reza Dehpour

    Version of Record online : 9 MAR 2007, DOI: 10.1111/j.1478-3231.2007.01457.x

  3. The role of the interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats

    Fundamental & Clinical Pharmacology

    Volume 15, Issue 3, June 2001, Pages: 181–187, Arezo Nahavandi, Ali Reza Mani, Homayoun Homayounfar, Mohammd Reza Akbari and Ahmad Reza Dehpour

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1472-8206.2001.00028.x

  4. The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue 1, January 2002, Pages: 96–101, HOUMAN HOMAYOUN, MOHAMMAD SAYYAH and AHMAD REZA DEHPOUR

    Version of Record online : 15 MAR 2002, DOI: 10.1046/j.1440-1746.2002.02658.x

  5. Opioid antagonists for alcohol dependence

    Intervention Review

    The Cochrane Library

    Susanne Rösner, Andrea Hackl-Herrwerth, Stefan Leucht, Simona Vecchi, Manit Srisurapanont and Michael Soyka

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD001867.pub3

  6. Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review

    CNS Neuroscience & Therapeutics

    Volume 17, Issue 6, December 2011, Pages: 629–636, Philipp P. Lobmaier, Nikolaj Kunøe, Michael Gossop and Helge Waal

    Version of Record online : 23 SEP 2010, DOI: 10.1111/j.1755-5949.2010.00194.x

  7. A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence

    Drug and Alcohol Review

    Volume 33, Issue 2, March 2014, Pages: 115–128, Sarah Larney, Linda Gowing, Richard P. Mattick, Michael Farrell, Wayne Hall and Louisa Degenhardt

    Version of Record online : 3 DEC 2013, DOI: 10.1111/dar.12095

  8. Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: Interaction between opioid and cannabinoid systems

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 7pt2, July 2008, Pages: e251–e257, Hamed Shafaroodi, Mehdi Ghasemi and Ahmad R Dehpour

    Version of Record online : 30 AUG 2007, DOI: 10.1111/j.1440-1746.2007.05101.x

  9. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

    Addiction

    Volume 108, Issue 2, February 2013, Pages: 275–293, Natalya C. Maisel, Janet C. Blodgett, Paula L. Wilbourne, Keith Humphreys and John W. Finney

    Version of Record online : 17 OCT 2012, DOI: 10.1111/j.1360-0443.2012.04054.x

  10. You have free access to this content
    Improving clinical outcomes for naltrexone as a management of problem alcohol use

    British Journal of Clinical Pharmacology

    Volume 76, Issue 5, November 2013, Pages: 632–641, Gary K. Hulse

    Version of Record online : 21 OCT 2013, DOI: 10.1111/j.1365-2125.2012.04452.x

  11. Sustained-Release Naltrexone For Opioid Dependence

    Intervention Review

    The Cochrane Library

    Philipp Lobmaier, Hege Kornor, Nikolaj Kunoe and Arild Bjørndal

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006140.pub2

  12. You have free access to this content
    Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

    Arthritis & Rheumatism

    Volume 65, Issue 2, February 2013, Pages: 529–538, Jarred Younger, Noorulain Noor, Rebecca McCue and Sean Mackey

    Version of Record online : 28 JAN 2013, DOI: 10.1002/art.37734

  13. Naltrexone and Dysphoria: Fact or Myth?

    The American Journal on Addictions

    Volume 11, Issue 2, Spring 2002, Pages: 151–160, Karen Miotto, Michael McCann, Janice Basch, Richard Rawson and Walter Ling

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490290087929

  14. Naltrexone, opiate addiction, and endorphins

    Medicinal Research Reviews

    Volume 2, Issue 3, July/September 1982, Pages: 211–246, Mark S. Gold, Charles A. Dackis, A. L. C. Pottash, Harvey H. Sternbach, William J. Annitto, David Martin and Marcy Pasternak Dackis

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610020302

  15. Naltrexone maintenance for heroin dependence: uptake, attrition and retention

    Drug and Alcohol Review

    Volume 23, Issue 3, September 2004, Pages: 299–309, Dr THAMIZAN K. TUCKER, ALISON J. RITTER, CLAIRE MAHER and HENRY JACKSON

    Version of Record online : 29 MAY 2009, DOI: 10.1080/09595230412331289464

  16. Oral naltrexone maintenance treatment for opioid dependence

    Intervention Review

    The Cochrane Library

    Silvia Minozzi, Laura Amato, Simona Vecchi, Marina Davoli, Ursula Kirchmayer and Annette Verster

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD001333.pub4

  17. Effects of Naltrexone Treatment for Alcohol-Related Disorders on Healthcare Costs in an Insured Population

    Alcoholism: Clinical and Experimental Research

    Volume 34, Issue 6, June 2010, Pages: 1090–1097, Henry R. Kranzler, Leslie B. Montejano, Judith J. Stephenson, Shaohung Wang and David R. Gastfriend

    Version of Record online : 5 APR 2010, DOI: 10.1111/j.1530-0277.2010.01185.x

  18. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research

    Addiction

    Volume 108, Issue 2, February 2013, Pages: 233–247, Hendrée E. Jones, Margaret S. Chisolm, Lauren M. Jansson and Mishka Terplan

    Version of Record online : 4 APR 2012, DOI: 10.1111/j.1360-0443.2012.03811.x

  19. You have free access to this content
    Injectable and implantable sustained release naltrexone in the treatment of opioid addiction

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 264–271, Nikolaj Kunøe, Philipp Lobmaier, Hanh Ngo and Gary Hulse

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12011

  20. You have free access to this content
    Kinetics and inhibition of the formation of 6β-naltrexol from naltrexone in human liver cytosol

    British Journal of Clinical Pharmacology

    Volume 50, Issue 5, November 2000, Pages: 465–471, Susan J. Porter, Andrew A. Somogyi and Jason M. White

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00281.x